Closure of Trading Window
Omkar Speciality Chemicals Ltd has informed BSE that the Trading Window for dealing in the securities of the Company will be closed for all Directors / Officers/ Designated Employees of the Company from March 28, 2016 to March 30, 2016 (both days inclusive). The trading window shall open on March 31, 2016.The communication has been sent to the Directors / Officers/ Designated Employees of the Company. Journalism students receive threat for inviting Kanhaiya
A non-cognisable offence registered against one Omkar Kadam, believed to be worker of Bhartiya Janata Yuva Morcha Intimation of Incorporation of a Wholly Owned Subsidiary Company
Omkar Speciality Chemicals Ltd has informed BSE regarding "Intimation of Incorporation of a Wholly Owned Subsidiary Company". Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Pravin S Herlekar has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Transcript of Earnings Conference Call
Omkar Speciality Chemicals Ltd has informed BSE regarding "Transcript of Earnings Conference Call". Updates on Intimation of conference call
Omkar Speciality Chemicals Ltd has informed BSE about the Intimation of conference call for the unaudited financial results for the quarter and nine months ended December 31, 2015. Intimation of conference call
Omkar Speciality Chemicals Ltd has informed BSE regarding "Intimation of conference call". Statement of Deviation or Variation for the Quarter Ended December 31, 2015
Omkar Speciality Chemicals Ltd has submitted to BSE a copy of Statement of Deviation or Variation for the Quarter Ended December 31, 2015. Shareholding for the Period Ended December 31, 2015
Omkar Speciality Chemicals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Financial Results, Limited Review Report for December 31, 2015
Omkar Speciality Chemicals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Consolidated Financial Results for the period ended December 31, 20153. Standalone Limited Review for the period ended December 31, 2015